Insomnia and telomere length in older adults

Sleep

Volumn 39, Issue 3, 2016, Pages 559-564

  Carroll, Judith E ^a   Esquivel, Stephanie ^a   Goldberg, Alyssa ^a,c   Seeman, Teresa E ^b   Effros, Rita B ^b   Dock, Jeffrey ^b   Olmstead, Richard ^a   Breen, Elizabeth C ^a   Irwin, Michael R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Aging; Cellular aging; Insomnia; Late life; Older adults; Sleep; Telomere

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CELL AGING; CELLULAR PARAMETERS; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY INSOMNIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TELOMERE; TELOMERE LENGTH; VERY ELDERLY; AGING; CASE CONTROL STUDY; CHRONIC DISEASE; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; RISK; SLEEP INITIATION AND MAINTENANCE DISORDERS;

AGED; AGED, 80 AND OVER; AGING; CASE-CONTROL STUDIES; CELL AGING; CHRONIC DISEASE; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RISK; SLEEP INITIATION AND MAINTENANCE DISORDERS; TELOMERE;

EID: 84960361690     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.5526     Document Type: Article

References (66)

1. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97-111.
2. Morin CM, LeBlanc M, Daley M, Gregoire J P, Mérette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 2006;7:123-30.
3. Leger D, Guilleminault C, Dreyfus J P, Delahaye C, Paillard M. Prevalence of insomnia in a survey of 12778 adults in France. J Sleep Res 2000;9:35-42.
4. Dzierzewski JM, O'Brien EM, Kay D, McCrae CS. Tackling sleeplessness: psychological treatment options for insomnia in older adults. Nat Sci Sleep 2010;2:47-61.
5. Vgontzas AN, Liao D, Pejovic S, et al. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep 2010;33:1159-64.
6. Rod NH, Kumari M, Lange T, Kivimäki M, Shipley M, Ferrie J. The joint effect of sleep duration and disturbed sleep on cause-specific mortality: results from the Whitehall II cohort study. PLoS One 2014;9:e91965.
7. Ensrud K E, Blackwell TL, Ancoli-Israel S, et al. Sleep distu rbances and risk of frailty and mortality in older men. Sleep Med 2012;13:1217-25.
8. Li Y, Zhang X, Winkelman JW, et al. Association between insomnia symptoms and mortality: a prospective study of U. S. men. Circulation 2014;129:737-46.
9. Vgontzas AN, Fernandez-Mendoza J. Insomnia with short sleep duration: nosological, diagnostic, and treatment implications. Sleep Med Clin 2013;8:309-22.
10. Cribbet MR, Carlisle M, Cawthon RM, et al. Cellular aging and restorative processes: subjective sleep quality and duration moderate the association between age and telomere length in a sample of middleaged and older adults. Sleep 2014;37:65-70.
11. Jackowska M, Hamer M, Carvalho LA, Erusalimsky JD, Butcher L, Steptoe A. Short sleep duration is associated with shorter telomere length in healthy men: findings from the Whitehall II Cohort Study. Kiechl S, ed. PLoS One 2012;7:e47292.
12. Prather AA, Puterman E, Lin J, et al. Shorter leukocyte telomere length in midlife women with poor sleep quality. J Aging Res 2011;2011:721390.
13. Liang G, Schernhammer E, Qi L, Gao X, De Vivo I, Han J. Associations between rotating night shifts, sleep duration, and telomere length in women. PLoS One 2011;6:e23462.
14. Chen S, Lin J, Matsuguchi T, et al. Short leukocyte telomere length predicts incidence and progression of carotid atherosclerosis in American Indians: the Strong Heart Family Study. Aging (Albany NY) 2014;6:414-27.
15. Carroll JE, Cole SW, Seeman TE, et al. Partial sleep deprivation activates the DNA damage response (DDR) and the senescenceassociated secretory phenotype (SASP) in aged adult humans. Brain Behav Immun 2016;51:223-9.
16. Everson CA, Henchen CJ, Szabo A, Hogg N. Cell injury and repair resulting from sleep loss and sleep recovery in laboratory rats. Sleep 2014;37:1929-40.
17. Irwin M R, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry 2015 Jun. 1. [Epub ahead of print].
18. Erusalimsky JD. Vascular endothelial senescence: from mechanisms to pathophysiology. J Appl Physiol 2009;106:326-32.
19. Houben JMJ, Moonen HJJ, Van Schooten FJ, Hageman GJ. Telomere length assessment: biomarkers of chronic oxidative stress? Free Radic Biol Med 2008;44:235-46.
20. Jiang H, Ju Z, Rudolph KL. Telomere shortening and ageing. Z Gerontol Geriatr 2007;40:314-24.
21. Von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002;27:339-44.
22. Baragetti A, Palmen J, Garlaschelli K, et al. Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population. J Intern Med 2015;277:478-87.
23. Duggan C, Risques R, Alfano C, et al. Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors. J Natl Cancer Inst 2014;106:dju035.
24. Barrett ELB, Burke TA, Hammers M, Komdeur J, Richardson DS. Telomere length and dynamics predict mortality in a wild longitudinal study. Mol Ecol 2013;22:249-59.
25. Epel ES, Merkin SS, Cawthon R, et al. The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging (Albany NY) 2009;1:81-8.
26. Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ 2014;349:g4227.
27. Cao W, Jamieson BD, Hultin LE, Hultin PM, Effros R B, Detels R. Premature aging of T cells is associated with faster HIV-1 disease progression. J Acquir Immune Defic Syndr 2009;50:137-47.
28. Sahin E, Colla S, Liesa M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011;470:359-65.
29. Taffett GE. Physiology of Aging. In: Cassel CK, ed. Geriatric medicine: an evidence-based approach, 4th ed. New York, NY: Springer-Verlag, 2003:27-35.
30. Lee KA, Gay C, Humphreys J, Portillo CJ, Pullinger CR, Aouizerat BE. Telomere length is associated with sleep duration but not sleep quality in adults with human immunodeficiency virus. Sleep 2014;37:157-66.
31. Prather AA, Gurfein B, Moran P, et al. Tired telomeres: poor global sleep quality, perceived stress, and telomere length in immune cell subsets in obese men and women. Brain Behav Immun 2015;47:155-62.
32. Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study. Diabetes Care 2009;32:1980-5.
33. Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 2009;32:491-7.
34. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association, 2000.
35. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 2nd ed. Westchester, IL: American Academy of Sleep Medicine, 2005.
36. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002;30:47e-47.
37. Rickabaugh TM, Kilpatrick RD, Hultin LE, et al. The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment. PLoS One 2011;6:e16459.
38. Kilpatrick RD, Rickabaugh T, Hultin LE, et al. Homeostasis of the naive CD4+ T cell compartment during aging. J Immunol 2008;180:1499-507.
39. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
40. Willeit P, Willeit J, Brandstätter A, et al. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler Thromb Vasc Biol 2010;30:1649-56.
41. Kourtis N, Tavernarakis N. Cellular stress response pathways and ageing: intricate molecular relationships. EMBO J 2011;30:2520-31.
42. Campisi J, D'Adda Di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007;8:729-40.
43. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005;120:513-22.
44. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011;192:547-56.
45. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 2014;69:S4-9.
46. Effros RB. The role of CD8 T cell replicative senescence in human aging. Discov Med 2005;57:293-7.
47. Irwin MR. Why sleep is impor tant for health: a psychoneuroimmunology perspective. Annu Rev Psychol 2015;66:143-72.
48. Burgos I, Richter L, Klein T, et al. Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav Immun 2006;20:246-53.
49. Vgontzas AN, Zoumakis M, Papanicolaou DA, et al. Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism 2002;51:887-92.
50. Liukkonen T, Räsänen P, Ruokonen A, et al. C-reactive protein levels and sleep disturbances: observations based on the Northern Finland 1966 Birth Cohort study. Psychosom Med 2007;69:756-61.
51. Zhang J, Lamers F, Hickie IB, He J-P, Feig E, Merikangas KR. Differentiating nonrestorative sleep from nocturnal insomnia symptoms: demographic, clinical, inflammatory, and functional correlates. Sleep 2013;36:671-9.
52. Okun ML, Coussons-Read M, Hall M. Disturbed sleep is associated with increased C-reactive protein in young women. Brain Behav Immun 2009;23:351-4.
53. Suarez EC. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun 2008;22:960-8.
54. Irwin MR, Olmstead R, Carrillo C, et al. Cognitive behavioral therapy vs. tai chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial. Sleep 2014;37:1543-52.
55. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2006;908:244-54.
56. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A 2003;100:9090-5.
57. McEwen BS. Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load. Metabolism 2006;55:S20-3.
58. Seeman TE, Singer BH, Rowe JW, Horwitz RI, McEwen BS. Price of adaptation-allostatic load and its health consequences. MacArthur studies of successful aging. Arch Intern Med 1997;157:2259-68.
59. Picard M, Juster R-P, McEwen BS. Mitochondrial allostatic load puts the "gluc" back in glucocorticoids. Nat Rev Endocrinol 2014;10:303-10.
60. Carroll JE, Irwin MR, Merkin SS, Seeman TE. Sleep and multisystem biological risk: a population-based study. PLoS One 2015;10:e0118467.
61. Daniali L, Benetos A, Susser E, et al. Telomeres shorten at equivalent rates in somatic tissues of adults. Nat Commun 2013;4:1597.
62. Lin J, Epel E, Cheon J, et al. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J Immunol Methods 2010;352:71-80.
63. Lin Y, Damjanovic A, Metter EJ, et al. Age-associated telomere attrition of lymphocytes in vivo is co-ordinated with changes in telomerase activity, composition of lymphocyte subsets and health conditions. Clin Sci (Lond) 2015;128:367-77.
64. Blackburn EH. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett 2005;579:859-62.
65. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep 2006;29:1398-414.
66. Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol 2006;25:3-14.